TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/15/24 10:49 | 3/15/24 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Kumar Amit | CA | O | CEO | P | 97 | 3.22 | 0 | 30 | 6 | 492 | D | ||||||||||||||
7/31/23 18:34 | 7/28/23 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Kumar Amit | CA | DO | CEO | M.d | 103 | 2.58 | 0 | 40 | 9 | 462 | D | ||||||||||||||
7/31/23 18:34 | 7/31/23 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Kumar Amit | CA | DO | CEO | S.d | -42 | 3.57 | 0 | -12 | -2 | 462 | D | ||||||||||||||
9/16/22 17:20 | 9/15/22 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Kumar Amit | CA | DO | CEO | M.d | 1,648 | 2.58 | 0 | 640 | 462 | D | |||||||||||||||
1/7/22 10:32 | 1/7/22 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Kumar Amit | CA | DO | CEO | P | 60 | 3.00 | 0 | 20 | 7 | 314 | D | ||||||||||||||
11/1/21 11:05 | 10/29/21 | ANIX | Anixa Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Kumar Amit | CA | DO | CEO | P | 10 | 4.77 | 0 | 2 | 1 | 294 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |